CHENGDU HUACHUANG BIOTECHNOLOGY CO LTD has a total of 26 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and pharmaceuticals are SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RES INSTITUTE), NANTKWEST INC and SEATTLE CHILDREN S HOSPITAL DBA SEATTLE CHILDREN S RES INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | China | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United States | 5 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Yan Juan | 26 |
#2 | Chen Shouchun | 26 |
#3 | Hu Haiyang | 26 |
#4 | Xu Qi | 25 |
#5 | Wei Lijia | 24 |
#6 | Huang Xianzhou | 24 |
#7 | Pan Feng | 2 |
#8 | Xuqi | 1 |
#9 | Ding Yi | 1 |
#10 | Li Zhaojun | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020037714A1 | Application of trail mutants in preparation of medicines for treating acnes, and preparation | |
WO2019000327A1 | Method for administering trail protein so as to continuously inhibit tumor cell growth | |
EP3348578A1 | Double-target mutein mur6s4tr of trail, and preparation method and use thereof | |
CN106459172A | TRAIL double target mutant protein MuR5S4TR, and preparation method and application thereof | |
WO2016138625A1 | Trail membrane-penetrating peptide-like mutant mur6, preparation method therefor, and application thereof | |
CN106132986A | TRAIL cell-penetrating peptide sample mutant MuR5, preparation method and application | |
WO2015078237A1 | Double target fusion protein increasing trail antitumor activity and in vitro expression method and application thereof | |
CN103555729A | Modified TRAIL gene sequence, expression method and application |